Encinitas, California
United States
125
2024-09-05
The entities that hold a legal rights for patent applications filed by inventor Monia Brett P.:
Brett P. Monia from Encinitas, US has applied for patents for these inventions. The list has both pending applications and granted patents:
GLP-1 RECEPTOR LIGAND MOIETY CONJUGATED OLIGONUCLEOTIDES AND USES THEREOF
#2 | 2024-04-25MODULATION OF TRANSTHYRETIN EXPRESSION
#3 | 2023-08-24MODULATION OF FACTOR 11 EXPRESSION
#4 | 2023-07-06METHODS AND COMPOSITIONS FOR MODULATING ALPHA-1-ANTITRYPSIN EXPRESSION
#5 | 2023-01-05Compounds and methods for modulating factor XII
#6 | 2022-03-10METHODS AND COMPOSITIONS FOR MODULATING ALPHA-1-ANTITRYPSIN EXPRESSION
#7 | 2021-11-11GLP-1 receptor ligand moiety conjugated oligonucleotides and uses thereof
#8 | 2021-09-09METHODS FOR SAFELY REDUCING THROMBOPOIETIN
#9 | 2021-06-10Modulation of factor 11 expression
#10 | 2021-04-01Modulation of transthyretin expression
#11 | 2020-08-27GLP-1 RECEPTOR LIGAND MOIETY CONJUGATED OLIGONUCLEOTIDES AND USES THEREOF
#12 | 2020-05-21METHODS AND COMPOSITIONS FOR MODULATING ALPHA-1-ANTITRYPSIN EXPRESSION
#13 | 2020-01-02Modulation of Factor 11 expression
#14 | 2019-08-08Modulators of DNM2 expression
#15 | 2019-06-06MODULATION OF TRANSTHYRETIN EXPRESSION
#16 | 2019-05-09GLP-1 Receptor Ligand Moiety Conjugated Oligonucleotides and Uses Thereof
#17 | 2019-03-07Modulation of DYRK1B expression
#18 | 2018-09-27MODULATION OF TRANSTHYRETIN EXPRESSION
#19 | 2018-08-16METHODS AND COMPOSITIONS FOR MODULATING ALPHA-1-ANTITRYPSIN EXPRESSION
#20 | 2017-02-09MODULATION OF FACTOR 11 EXPRESSION
#21 | 2016-12-22Modulation of transthyretin expression
#22 | 2016-12-15Methods and compositions for modulating alpha-1 antitrypsin expression
#23 | 2015-12-03Compounds and methods for modulating gene expression
#24 | 2015-09-24Oligomeric compounds comprising bicyclic nucleosides and uses thereof
#25 | 2015-09-10Modulation of transthyretin expression
#26 | 2015-03-26Methods and compositions for modulating alpha-1-antitrypsin expression
#27 | 2015-02-26COMPOUNDS AND METHODS FOR MODULATING EXPRESSION APOB
#28 | 2014-12-04CHIMERIC OLIGOMERIC COMPOUNDS COMPRISING ALTERNATING REGIONS OF NORTHERN AND SOUTHERN CONFORMATIONAL GEOMETRY
#29 | 2014-09-11Modulation of transthyretin expression
#30 | 2014-07-03ANTISENSE OLIGONUCLEOTIDE MODULATION OF RAF GENE EXPRESSION
#31 | 2014-04-15Diagnosis and treatment of disease
#32 | 2013-12-12Methods for modulating factor 12 expression
#33 | 2013-11-07ANTIDOTES TO ANTISENSE COMPOUNDS
#34 | 2013-10-17Modulation of factor 11 expression
#35 | 2013-07-25MODULATION OF FACTOR 11 EXPRESSION
#36 | 2013-06-27Compounds and methods for modulating expression of DGAT2
#37 | 2013-05-16Modulation of diacylglycerol acyltransferase 2 expression
#38 | 2013-05-02COMPOSITIONS AND THEIR USES DIRECTED TO ACEYTL-COA CARBOXYLASES
#39 | 2013-03-28ANTISENSE OLIGONUCLEOTIDE MODULATION OF RAF GENE EXPRESSION
#40 | 2012-09-13MODULATION OF DIACYLGLYCEROL ACYLTRANSFERASE 1 EXPRESSION
#41 | 2012-08-23MODULATION OF FACTOR 7 EXPRESSION
#42 | 2012-08-16COMPOUNDS AND METHODS FOR MODULATING EXPRESSION OF GCGR
#43 | 2012-08-02MODULATION OF SGLT-2 EXPRESSION
#44 | 2012-07-19ANTISENSE INHIBITION VIA RNASE H-INDEPENDENT REDUCTION IN MRNA
#45 | 2012-06-14ANTISENSE OLIGONUCLEOTIDE MODULATION OF RAF GENE EXPRESSION
#46 | 2012-05-10COMPOSITIONS AND THEIR USES DIRECTED TO HEPCIDIN
#47 | 2012-04-05MODULATION OF INFLAMMATORY RESPONSES BY FACTOR XI
#48 | 2012-03-29Antisense modulation of PTP1B expression
#49 | 2012-02-02Compositions and their uses directed to diacylglycerol acyltransferase 1
#50 | 2011-12-01MODULATION OF TRANSTHYRETIN EXPRESSION
#51 | 2011-09-29MODULATION OF TRANSTHYRETIN EXPRESSION FOR THE TREATMENT OF CNS RELATED DISORDERS
#52 | 2011-08-25ENHANCED ANTISENSE OLIGONUCLEOTIDES
#53 | 2011-07-21METHODS FOR MODULATING EXPRESSION OF CREB
#54 | 2011-07-14Conjugates For Use In Hepatocyte Free Uptake Assays
#55 | 2011-06-09Compositions and their uses directed to acetyl-CoA carboxylases
#56 | 2011-05-26Methods for modulating expression of RBP4
#57 | 2011-03-10MODULATION OF FACTOR 9 EXPRESSION
#58 | 2010-12-30Antidotes to antisense compounds
#59 | 2010-12-23Modulation of SGLT2 expression
#60 | 2010-12-09Modulation of diacylglycerol acyltransferase 2 expression
#61 | 2010-11-25Modulation of factor 7 expression
#62 | 2010-09-02MODULATION OF GLUCOCORTICOID RECEPTOR EXPRESSION
#63 | 2010-08-12Modulation of Stat 6 Expression for the Treatment of Airway Hyperresponsiveness
#64 | 2010-06-03Modulation of factor 11 expression
#65 | 2010-02-11Antisense modulation of connective tissue growth factor expression
#66 | 2009-12-31COMPOUNDS AND METHODS FOR MODULATING EXPRESSION OF CRP
#67 | 2009-12-31COMPOUNDS AND METHODS FOR MODULATING EXPRESSION OF SGLT2
#68 | 2009-12-24Compounds and methods for modulating expression of PTP1B
#69 | 2009-12-10Compounds and methods for modulating expression of GCCR
#70 | 2009-12-10Compounds and methods for modulating expression ApoB
#71 | 2009-12-10Compounds and methods for modulating expression of GCGR
#72 | 2009-12-10Compounds and methods for modulating expression of PCSK9
#73 | 2009-11-26COMPOUNDS AND METHODS FOR MODULATING EXPRESSION OF DGAT2
#74 | 2009-10-15Chimeric oligomeric compounds comprising alternating regions of northern and southern conformational geometry
#75 | 2009-05-14Antisense modulation of PTP1B expression
#76 | 2009-04-23Modulation of diacylglycerol acyltransferase 1 expression
#77 | 2009-02-26Compositions and their uses directed to diacylglycerol acyltransferase 1
#78 | 2009-02-05Antisense Modulation of PTP1B Expression
#79 | 2008-12-18Isis Pharmaceuticals, Inc.
#80 | 2008-08-19Modulation of diacylglycerol acyltransferase 1 expression
#81 | 2008-01-17Short antisense compounds with gapmer configuration
#82 | 2007-12-27BACKBONE MODIFICATIONS TO MODULATE OLIGONUCLEOTIDE TARGETING IN VIVO
#83 | 2007-11-29Compositions and their uses directed to hepcidin
#84 | 2007-04-19Modulation of glucagon receptor expression
#85 | 2007-03-22Modulation of glucocorticoid receptor expression
#86 | 2007-03-01Antisense modulation of fibroblast growth factor receptor 3 expression
#87 | 2007-02-08GAPPED 2' MODIFIED OLIGONUCLEOTIDES
#88 | 2006-12-12Antisense modulation of bcl-x expression
#89 | 2006-11-30GAPPED 2' MODIFIED OLIGONUCLEOTIDES
#90 | 2006-11-16Modulation of STAT 6 expression for the treatment of airway hyperresponsiveness
#91 | 2006-07-20Antisense modulation of CD40 ligand expression
#92 | 2006-07-13Modulation of SLC26A2 expression
#93 | 2006-06-29Antisense oligonucleotide modulation of raf gene expression
#94 | 2006-04-27Antisense modulation of PTP1B expression
#95 | 2006-04-20Conjugates for use in hepatocyte free uptake assays
#96 | 2006-04-06Antisense modulation of matrix metalloproteinase 1 expression
#97 | 2006-03-23Enhanced antisense oligonucleotides
#98 | 2006-02-02Antisense modulation of PTP1B expression
#99 | 2006-01-26Antisense modulation of MEKK4 expression
#100 | 2006-01-05Compositions and their uses directed to bone growth modulators
167582 ⎘